HAV IgM ho'āʻo i ka Pepa ʻoki ʻole ʻia

Hoʻokumu ʻia ka maʻi hepatitis A e ka maʻi hepatitis A (HAV) a ua lawe ʻia ma ke ala fecal-oral, ka hapa nui mai nā maʻi.ʻO ka manawa incubation o ka maʻi hepatitis A he 15-45 mau lā, a loaʻa pinepine ka maʻi i loko o ke koko o ka mea maʻi a me nā feces 5-6 mau lā ma mua o ka piʻi ʻana o ka transcarbidine.Ma hope o 2-3 mau pule o ka hoʻomaka ʻana, me ka hana ʻana o nā antibodies kikoʻī i loko o ka serum, e nalowale ka infectivity o ke koko a me nā feces.I ka wā o ka maʻi hepa A, hiki i ke kino ke hana i nā antibodies.ʻElua ʻano o nā mea ʻeleʻele (anti-HAV) i ka serum, anti-HAVIgM a me anti-HAVIgG.Hōʻike koke ʻia ʻo Anti-HAVIgM, ʻike pinepine ʻia i loko o kekahi mau lā o ka hoʻomaka ʻana, a piʻi ka manawa jaundice, he hōʻailona koʻikoʻi ia no ka ʻike mua ʻana o ka maʻi hepa A. Hōʻike ʻia ʻo Anti-HAVIgG i ka lohi a lōʻihi loa, pinepine ʻino i ka pae mua o ka maʻi, a hōʻike ka anti-HAVIgG maikaʻi i ka maʻi HAV mua a hoʻohana pinepine ʻia i nā noiʻi epidemiological.ʻO ka hoʻokolohua microbiological o ka maʻi hepa A i hoʻokumu nui ʻia ma nā antigens a me nā antibodies o ka maʻi hepatitis A.Loaʻa nā ʻano noiʻi i ka microscopy immunoelectron, hoʻāʻo hoʻopili hoʻohui, immunoadhesion hemagglutination test, solid-phase radioimmunoassay a me ka enzyme-linked immunosorbent assay, polymerase chain reaction, cDNA-RNA molecular hybridization technology, etc.